Some GLP-1 companies facing lawsuits over vision loss. What to know - WLWT

As reported by WLWT Cincinnati

Some of the companies that produce GLP-1 drugs like Ozempic and Zepbound are facing lawsuits alleging that the drugs caused vision loss. Here's what to know.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on WLWT Cincinnati ↗

Market Samachar is a news aggregator. This article was originally published by WLWT Cincinnati. Tap the button above to read the full story on their site.

INDIAN Can Coal India’s higher realizations sustain its stock recovery? mint - markets
INDIAN JK Cement’s timely capacity ramp-ups give it bandwidth to beat FY27 volume goals mint - markets
INDIAN Small-cap IT stock under ₹50 jumps 17% as US subsidiary gets AI project worth ₹147 crore mint - markets
INDIAN Adani Power shares up over 30% in last 6 months - PL Capital sees a further 30% upside - Price target, rationale mint - markets
COMPANIES How to trade PB Fintech shares after falling 12% from day’s high? This technical analyst explains Stocks-Markets-Economic Times
COMPANIES Balrampur Chini Mills shares rally 4% as company receives Rs 75 crore BioE3 grant from government Stocks-Markets-Economic Times
INDIAN Global Market: Hong Kong stocks slide as investors await Trump-Xi summit details Markets-Economic Times
INDIAN Nebius shares rally up to 8%: What’s driving the AI rally? Markets-Economic Times

Some GLP-1 companies facing lawsuits over vision loss. What to know - WLWT

More from Market Samachar